Y Xiong, W Wang, Q Deng, Z Zhang, Q Wang, Z Yong… - Nano Today, 2023 - Elsevier
A variety of Poly (ADP-ribose) polymerase inhibitors (PARPi) have been approved for the
clinical treatment of breast cancers. However, pre-clinical and clinical evidences indicate …